Since the NDKA codifying gene (NME1) was first described as a putative tumour suppressor implicated in the metastatic process in melanoma and breast carcinoma13, the concern about the role of this protein in these and other human cancers has extended. The gene discussed is NME1; the disease is neoplasm.